PUBLISHER: IMARC | PRODUCT CODE: 1541496
PUBLISHER: IMARC | PRODUCT CODE: 1541496
The global surgical drainage devices market size reached US$ 1.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.5 Billion by 2032, exhibiting a growth rate (CAGR) of 3.5% during 2024-2032.
Surgical drainage devices are used to remove the contents of different organs, secretion of body cavities, and blood, serum, lymph, and other tissue fluids that accumulate in wound beds after surgical procedures. These devices minimize pressure on the surgical site and adjacent organs, nerves, and blood vessels, thereby reducing pain and enhancing wound perfusion and healing. They find application in urinary catheters, nasogastric tubes, chest drainage, and infected cysts. Presently, various surgical drainage devices made using latex, silicone, polyethylene, and polyvinyl chloride (PVC) are available worldwide, depending on the patient's surgery and wound.
A significant increase in the number of surgical procedures relating to the chest, lymph node, breast, abdominal, and thyroid represents one of the key factors propelling the market growth. Surgical drainage devices facilitate the healing process by removing inflammatory mediators, bacteria, foreign material, and necrotic tissues. Moreover, the rising demand for plastic surgery due to the increasing willingness among individuals to undergo reconstructive and cosmetic surgeries is bolstering the market growth. Apart from this, surgical drainage devices monitor potential complications and relieve the pressure that can impair perfusion or cause pain, thereby decreasing morbidity. Consequently, the rising incidence of neurosurgery with a high risk of raised intracranial pressure and orthopedic procedures associated with blood loss is influencing the market growth. Furthermore, they are widely being adopted in veterinary practice for surgical or traumatic wound management. The rising adoption of companion animals, along with the flourishing poultry and agriculture industries, is also contributing to market growth. Additionally, the growing focus on improving the functionality and reducing complications associated with drainage devices in surgeries is anticipated to drive the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global surgical drainage devices market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, application and end use.
Active
Passive
Cardio-Thoracic Surgeries
Neurosurgery Procedures
Abdominal Surgery
Orthopedics
Others
Hospitals
Clinics
Ambulatory Surgical Centers
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Acelity L.P. Inc. (3M Company), B. Braun Melsungen AG, Becton Dickinson and Company, Cardinal Health Inc., Cook Group Incorporated, Johnson & Johnson, Medela AG, Medtronic plc, Smith & Nephew plc, Stryker Corporation and Teleflex Incorporated.